Covira Surgical

Covira Surgical is a biotechnology company developing a novel platform to prevent post-surgical infections by modulating the gut microbiome. The company's lead product, Pi-PEG, is a non-antibiotic, oral therapeutic that coats the intestinal lining to suppress bacterial virulence without killing beneficial bacteria. By maintaining microbial harmony and protecting the intestinal barrier, Covira aims to reduce complications such as anastomotic leaks and surgical site infections in patients undergoing major gastrointestinal surgery. This approach addresses the critical need for infection prevention while avoiding the development of antibiotic resistance.